SYMBIOSIS GROUP
Symbiosis Group Limited is an investment company building a portfolio of innovative life science companies. It is focused on the commercialisation of life science discoveries emanating from one of Australia’s leading research intensive universities.
SYMBIOSIS GROUP
Status:
Closed
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-12 | Greenlight Biosciences | Symbiosis Group investment in Post-IPO Equity - Greenlight Biosciences | 109 M USD |
| 2021-04-15 | Biosplice Therapeutics | Symbiosis Group investment in Venture Round - Biosplice Therapeutics | 120 M USD |
| 2020-09-17 | Finch Therapeutics | Symbiosis Group investment in Series D - Finch Therapeutics | 90 M USD |
| 2019-05-13 | Vedanta Biosciences | Symbiosis Group investment in Series C - Vedanta Biosciences | 18.5 M USD |
| 2005-07-26 | Spinifex Pharmaceuticals | Symbiosis Group investment in Series A - Spinifex Pharmaceuticals | 3.25 M AUD |